1.An overview of alogliptin plus pioglitazone for the treatment of type 2 diabetes

Tomlinson, B, Chan,     More...

Tomlinson, B, Chan, P, Lam, CWK     Less

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2021, Volume 23, Issue 1, Pages 29-42

收錄情况： WOS SCOPUS

WOS核心合集引用: 4  2022影響因子:  3.2  发表年影響因子:  4.103 

2.The role of sulfonylureas in the treatment of type 2 diabetes

Tomlinson, B, Patil,     More...

Tomlinson, B, Patil, NG, Fok, M, Chan, P, Lam, CWK     Less

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2021, Volume 23, Issue 3, Pages 387-403

收錄情况： WOS SCOPUS

WOS核心合集引用: 13  2022影響因子:  3.2  发表年影響因子:  4.103 

3.Managing dyslipidemia in patients with Type 2 diabetes [Special Issue]

Tomlinson, B, Patil,     More...

Tomlinson, B, Patil, NG, Fok, M, Lam, CWK     Less

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2021, Volume 22, Issue 16, Pages 2221-2234

收錄情况： WOS SCOPUS

WOS核心合集引用: 12  2022影響因子:  3.2  发表年影響因子:  4.103 

4.Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy

Tomlinson, Brian, La     More...

Tomlinson, Brian, Lam, Christopher Wai Kei, Chan, Paul, Zhang, Yuzhen     Less

Expert Opinion on Pharmacotherapy[1465-6566], Published 2020, Volume 21, Issue 17, Pages 2137-2151

收錄情况： WOS SCOPUS

WOS核心合集引用: 6  2022影響因子:  3.2  发表年影響因子:  3.889